Literature DB >> 15934056

Direct targeting of human plasma for matrix-assisted laser desorption/ionization and analysis of plasma proteins by time of flight-mass spectrometry.

Ya Jin1, Takashi Manabe.   

Abstract

A method to analyze human plasma proteins without fractionation, directly applying a plasma-matrix mixture on the target plate of a matrix-assisted laser desorption/ionization-time of flight-mass spectrometer (MALDI-TOF-MS), has been described. Peaks of ionized plasma proteins could not be detected applying a mixture of an undiluted plasma sample and a matrix solution, but they appeared when the plasma was diluted before mixing with the matrix. Tenfold diluted plasma provided well-resolved protein peaks in the m/z range from 4000 to 30,000. The addition of a simple post-crystallization washing procedure performed on the target plate further improved the quality of mass spectra. We numbered 58 peaks in the range of 4-160 kDa and 32 out of which were assigned to the plasma protein species which have been reported. Especially high sensitivity and resolution were obtained in the region < 30 kDa, where multiple isoforms of apolipoprotein A-I, apolipoprotein A-II, apolipoprotein C-I, apolipoprotein C-II, apolipoprotein C-III, and transthyretin could be assigned. Various post-translational modifications are involved in the isoforms, e.g., proteolytic cleavage, glycosylation and chemical modifications. This method will become complementary with the present electrophoretic techniques, especially for the analysis of low-molecular-mass proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934056     DOI: 10.1002/elps.200410421

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  8 in total

1.  Protein separation and characterization by np-RP-HPLC followed by intact MALDI-TOF mass spectrometry and peptide mass mapping analyses.

Authors:  Claire Dauly; David H Perlman; Catherine E Costello; Mark E McComb
Journal:  J Proteome Res       Date:  2006-07       Impact factor: 4.466

2.  One-step isolation and biochemical characterization of a highly active plant PSII monomeric core.

Authors:  Cristina Pagliano; Fabiana Chimirri; Guido Saracco; Francesco Marsano; James Barber
Journal:  Photosynth Res       Date:  2011-04-13       Impact factor: 3.573

3.  Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.

Authors:  Shannon K Flood-Nichols; Deborah Tinnemore; Mark A Wingerd; Ali I Abu-Alya; Peter G Napolitano; Jonathan D Stallings; Danielle L Ippolito
Journal:  Mol Cell Proteomics       Date:  2012-10-10       Impact factor: 5.911

Review 4.  Glycosylation of HDL-Associated Proteins and Its Implications in Cardiovascular Disease Diagnosis, Metabolism and Function.

Authors:  Eduardo Z Romo; Angela M Zivkovic
Journal:  Front Cardiovasc Med       Date:  2022-05-27

5.  Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis.

Authors:  A Xue; C J Scarlett; L Chung; G Butturini; A Scarpa; R Gandy; S R Wilson; R C Baxter; R C Smith
Journal:  Br J Cancer       Date:  2010-06-29       Impact factor: 7.640

6.  Applying proteomic-based biomarker tools for the accurate diagnosis of pancreatic cancer.

Authors:  Kyoko Kojima; Senait Asmellash; Christopher A Klug; William E Grizzle; James A Mobley; John D Christein
Journal:  J Gastrointest Surg       Date:  2008-08-15       Impact factor: 3.452

Review 7.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

8.  Glycomic analysis of high density lipoprotein shows a highly sialylated particle.

Authors:  Jincui Huang; Hyeyoung Lee; Angela M Zivkovic; Jennifer T Smilowitz; Nancy Rivera; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2014-01-21       Impact factor: 4.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.